&w=3840&q=100)
Stock Market LIVE Updates: Sensex, Nifty trade flat; Defence stocks expensive, says Raamdeo Agrawal
10:23 AM
Stock Market LIVE Updates: Indian markets expensive, but not in bubble zone, says Raamdeo Agrawal
Stock Market LIVE Updates: Raamdeo Agrawal said net inflows in mutual funds have come down, and HNIs are taking bets in the cash market due to slowdown in earnings.
Indian markets are going through a transitionary phase, and will start picking pace by the end of CY-2025.
Indian stock market is not in a "broad-based bubble". However, there could be certain segments where there is froth.
Defence theme will last in India from a long-term perspective. That said, there are not enough companies with depth and skill to exploit order inflows due to 'Aatmanirbhar Bharat'
There is froth in defence stocks from near-term perspective.
10:16 AM
Stock Market LIVE Updates: Markets bottomed out in March, says Raamdeo Agrawal
Stock Market LIVE Updates: Sharing his views on the current market trend, stock market veteran Raamdeo Agrawal, chairman and co-founder of Motilal Oswal Financial Services said the markets bottomed out in March 2025. "Going ahead, we will see sequential improvement in earnings which will reflect in stock prices," he said in a television interview.
He also said:
>> Indian economy will see improvement in credit offtake during the festive season (October-December). Markets will have a gala time in January-March period.
>> Earnings will also see improvement in Q3FY26 due to festive season-led consumption boost
>> FIIs missed the rally in the Indian stock market over the past 3-4 years.
>> FIIs are bullish on India, but are looking for a steep correction to enter the market.
10:08 AM
Stock Market LIVE Updates: Crizac shares list at 14% premium
Stock Market LIVE Updates: Crizac shares listed at ₹280 per share, reflecting a premium of ₹35 or 14.29 per cent over the issue price of ₹245 per share. The Crizac IPO listing came in slightly lower than the grey market estimates. Ahead of their debut, the unlisted shares were changing hands at around ₹286.50 each, implying a grey market premium (GMP) of ₹41.50 or approximately 16.94 per cent over the IPO issue price, according to sources tracking unofficial market activity.
9:20 AM
Stock Market LIVE Updates: Sensex heatmap
Stock Market LIVE Updates: HCL Tech, Larsen & Toubro, Tata Motors, Tata Steel, and Mahindra & Mahindra were among the top laggards on Sensex.
9:15 AM
Stock Market LIVE Updates: Nifty50 opens at 25,514
Stock Market LIVE Updates: The NSE Nifty50 opened at 25,514.60, lower by 7.90 points or 0.03 per cent from its previous close.
9:10 AM
Stock Market LIVE Updates: Sensex sheds 86 points in pre-open
9:09 AM
Stock Market LIVE Updates: Nifty sheds 8 points in in pre-open
Connect with us on WhatsApp
First Published: Jul 09 2025 | 6:55 AM IST
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
29 minutes ago
- Mint
Anthem Biosciences IPO listing date today. GMP, analysts signal strong debut of shares in stock market today
Anthem Biosciences IPO Listing: Anthem Biosciences shares are set to make their debut in the Indian stock market today. The initial public offering (IPO) of specialized fermentation-based APIs manufacturer received stellar demand during its subscription period, and Anthem Biosciences IPO listing date is today. The public issue was open from July 14 to July 16, and Anthem Biosciences IPO allotment date was July 17. Anthem Biosciences IPO listing date is today, 21 July 2025. Anthem Biosciences shares will be listed today on both the stock exchanges, BSE and NSE. 'Trading Members of the Exchange are hereby informed that effective from Monday, July 21, 2025, the equity shares of Anthem Biosciences Limited shall be listed and admitted to dealings on the Exchange in the list of 'B' Group of Securities,' a notice on the BSE said. Anthem Biosciences shares will be a part of Special Pre-open Session (SPOS) on Monday, July 21, 2025, it added, and the stock will be available for trading from 10:00 AM. Ahead of Anthem Biosciences IPO listing today, investors watch out for the trends in grey market premium (GMP) in order to gauge the estimated listing price of the shares. Anthem Biosciences IPO GMP today and analysts signal a strong debut of shares in the Indian stock market today. Here's what Anthem Biosciences IPO GMP indicates: The trends for Anthem Biosciences shares in the unlisted market remains bullish with a strong grey market premium. According to stock market experts, Anthem Biosciences IPO GMP today is ₹ 177 per share. This indicates that Anthem Biosciences shares are available at a premium of ₹ 177 apiece in the grey market than their issue price of ₹ 570 per share. Anthem Biosciences IPO GMP today signals that the estimated Anthem Biosciences share listing price would be ₹ 747 apiece, which is at a 31.05% premium to the IPO price of ₹ 570 per share. Analysts also expect Anthem Biosciences shares to list at a strong premium to its issue price on the stock exchanges. 'Anthem Biosciences is expected to make a strong debut on the stock exchanges. Given the robust investor demand during the IPO particularly from institutional investors, the shares suggest a potential listing in the range of ₹ 700 or higher, translating into a premium of around 20–25%,' said Mahesh M. Ojha, AVP - Research & Business Development, Hensex Securities Pvt. Ltd.. According to him, from a fundamentals perspective, a premium listing appears reasonable. Harshal Dasani Business Head, INVasset PMS, noted that over the weekend, Anthem Biosciences IPO GMP rose further to ₹ 165–170, indicating a likely listing price of ₹ 735–740, or a listing gain of approximately 29%. 'This level of interest reflects extraordinary investor conviction and places Anthem in an elite bracket of biotech listings in India. With no fresh issue component, there is zero dilution and no pressure to deploy new capital. If Q2 earnings keep pace and listing trends match market buzz, Anthem Biosciences could well position itself as the poster child of India's biotech resurgence,' said Dasani. The bidding for the Anthem Biosciences IPO opened on Monday, July 14, and closed on Wednesday, July 16. The IPO allotment date was July 17, and the Anthem Biosciences IPO listing date is today, 21 July 2025. Anthem Biosciences shares will be listed on BSE and NSE. The ₹ 3,395.00-crore Anthem Biosciences IPO was entirely an offer-for-sale (OFS) of 5.96 crore equity shares, issued at a fixed IPO price band of ₹ 570 per share. Anthem Biosciences IPO was subscribed 63.86 times in total, as per the NSE subscription data. The retail portion was booked 5.64 times, while the Non Institutional Investors (NII) segment was subscribed 42.36 times. The Qualified Institutional Buyers (QIBs) category received 182.65 times subscription. JM Financial is the book-running lead manager of the Anthem Biosciences IPO, while Kfin Technologies is the registrar for the issue. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Scroll.in
29 minutes ago
- Scroll.in
China's export restrictions on rare earth minerals could work to India's advantage
Around 80 years ago, in an assertive move, India had imposed restrictions on the export of rare earth-rich monazite sands to the US. As one of the largest global producers of rare earth minerals at the time, New Delhi's actions caused consternation in Washington given the importance of these minerals to the US's atomic energy ambitions. The objective of the export controls by the newly independent Indian government was to build a domestic processing industry and support the country's industrial ambitions. Despite the initial disruption, this action eventually expedited efforts by the US to look for domestic sources of rare earths which led to the finding of the massive Mountain Pass mine in Nevada and, subsequently, the buildout of the US rare earths industry. This slice of history has several lessons for Indian – and US – policymakers as they seek to deal with China's restrictions on the export of seven medium and heavy rare earths and magnets, which is expected to severely disrupt the production lines of automakers, renewable energy developers and the defence industry. Supplies from China have resumed to some US and European Union companies following diplomatic negotiations, but Indian companies appear to have had no such luck. Maruti Suzuki, India's largest automaker, is planning to reduce production of its flagship electric sports utility vehicle, e-Vitara. Several renewable energy developers are considering invoking force majeure clauses, seeking exemption from their obligations. This also highlights the risk of disruptions to solar panel and wind turbine manufacturing and underlines the importance of rare earth magnets for a variety of high-tech industries and industrial uses. Even though India has the third-largest global reserves of rare earths, the country is highly dependent on imports of these minerals and magnets. In the fiscal year 2024-'25, India imported 53,748 metric tonnes of rare earth magnets and 2,270 tonnes of rare earth metals and compounds in 2023-'24, mainly from China. The main reason for this import dependence is the inability to build deep expertise in the processing and magnet-making segments of the rare earths supply chain. Furthermore, the monazite reserves in India are typically found along with thorium, a radioactive material which makes it more costly and technically complex to process. In contrast, the US and China have bastnaesite reserves, which have lower radiation levels. The Indian government has launched some promising steps to address this challenge such as expediting auctions for the domestic exploration of critical minerals, including rare earths. It is also reportedly in the process of launching a production-linked incentive scheme to encourage companies to expand the domestic processing of rare earths and magnet production. Given the scale of the challenge, it will be crucial for India to come up with a multi-pronged strategy. Here are some steps India could take in the short, medium and long-term. Diplomacy, trade deals It will be crucial for the government to engage diplomatically with China to facilitate a temporary easing of rare earth and magnet supplies for Indian companies, similar to steps undertaken by the US and European Union. India lacks the same economic leverage so some concessions will likely need to be made to facilitate imports. At the same time, the government can temporarily dilute localisation regulations so that domestic companies can undertake the sub-assembly of rare earth motors in China and import them to India. These don't appear to be subjected to export controls by the Chinese government. In parallel, India should pursue offtake agreements with international rare earth suppliers, such as Myanmar, Australia and Vietnam and build technological partnerships with countries that have built up expertise in heavy rare earths separation, such as in Japan and Malaysia. Offtake agreements are commitments to purchase a specified quantity of minerals in the future and help mining companies reduce the risk of investing given the long timeframe from exploration to production. Indian Rare Earths Limited, a state-owned company, is in the process of producing magnets from rare earths found within India, and could collaborate with international companies to further upgrade its technologies. Partnerships to build domestic capacity It will be crucial to incentivise the use of rare earth-free motors by domestic companies to derisk from China. There are several examples of international automakers, such as Nissan and Renault, building rare-earth free motors following the temporary restrictions of rare earths to Japan from China in 2010. The use of these motors however fizzled away after exports from China resumed. India could facilitate partnerships between domestic companies with Japanese and Taiwanese companies to licence these technologies and promote their use by domestic automakers through incentives and mandates. The qualification timelines for these motors are likely to be 12-18 months so it will be crucial to provide regulatory certainty to maintain their adoption even if the current restrictions are relaxed by China. India should also stockpile rare earth ores and metals for its defence industry through strategic public investments. Rare earths run the risk of oxidation, so stockpiles need to be carefully managed and mainly used for strategic purposes. Reforms, research India should also seek to accelerate the domestic exploration of rare earths through regulatory reforms. Although these reforms will need to be implemented soon, the long timelines associated with the mining industry mean that these mines will likely take several years before starting production. It is crucial to recognise that rare earths aren't the only elements where India has a strategic vulnerability. China's concentration in the processing of graphite is equally significant, and export restrictions on graphite-derived technologies, such as anodes used in EV batteries, is another strategic vulnerability. This is an area where India could have a comparative advantage by expanding synthetic graphite production, which is already being undertaken to some extent by domestic companies. Aside from building technical know-how and providing generous subsidies, China's success is also a result of outlining a clear vision in moving towards a low-carbon economy, which provides offtake certainty to mining and processing companies. Green technologies are anticipated to become the largest demand source of many critical minerals in the future, so accelerating domestic clean energy manufacturing ensures supply certainty for mining and processing companies. India can commit more fully towards clean energy technologies through regulatory frameworks, incentives and international collaborations, which can build economies of scale. China's rare earth restrictions should serve as a wake-up call for India to act decisively to secure its interests, as it did so in the past. Those who forget their history often fail to learn from it.
Time of India
an hour ago
- Time of India
AI-assisted coding is the way to go when hiring graduates: LTIMindtree CEO
Academy Empower your mind, elevate your skills Hiring for freshers or entry-level graduates will have artificial intelligence or AI-assisted coding as part of the improvised assessment as the correlation between revenue and headcount growth becomes more de-linear, said chief executive officer (CEO) of the sixth-largest Indian IT company, LTIMindtree 'We are very optimistic about continuing our effort in inducting freshers. We added 1,600 freshers this quarter and we are going to add more throughout this year as well. AI-assisted coding is the way to go about it,' said Venugopal Lambu Lambu said there was more emphasis in terms of the learning ability, and the foundational skill sets that freshers have on which companies can build, using their training and learning methods.'So those assessments will always improvise it…Whenever we hire people, we take all those aspects, whether it is related to the coding roles, cloud roles or infrastructure roles or data roles,' he on freshers by building a pyramid-style organisation structure has been key for the over-$283-billion outsourcing industry's services delivery model. However, over the past more than a year, since AI took centre-stage entry-level jobs and hiring at technology firms was impacted with companies coding 20-25% via AI, reducing the need for junior-level human AI technology permeates across functions and solutions, Lambu believes there is a correlation or a non-linearity in the revenue growth and workforce addition.'Over the last few quarters, when we added revenue, the headcount has not necessarily increased. So, there is a correlation or a non-linearity, but it is too early to call out to what extent it will happen,' he added. LTIMindtree , formed with the merger of L&T Infotech and Mindtree in November 2022, last week reported a 5.2% year-on-year growth in the first quarter revenue of fiscal year 2026 at $1.15 billion. It was a 1.97% sequential rise boosted by healthy growth from Europe and its consumer or retail transitioned to take over the Mumbai-headquartered Larsen & Toubro (L&T) subsidiary's top seat on May 31, after induction into the firm in company announced its largest deal with a US-based client worth $450 million in the first quarter.'We are on the verge of signing a couple of deals, and one of them will actually beat our own record. That gives me the confidence that we will move towards the double-digit growth at some time in the second half of the year,' Lambu IT industry has been struggling with low single-digit to flat business growth over the past two years after more than two decades of strong double-digit revenue growth tariff-led macro uncertainties and the AI-backed efficiencies increase cost pressures, most software service providers are witnessing a demand contraction from top clients. This is lowering revenue contribution from large deals, a key vector for IT firms' growth.'Our contribution of top clients' revenue decreased because it has moved to the other categories. For example, we added two new $50 million-plus accounts on-year basis…The portfolio mix also is changing as we start building larger deals,' Lambu we are betting big on AI, Lambu said, AI will be net positive for both revenue and margin growth, which it expects to be closer to 16% in the next couple of quarters from 14.3% in the June quarter.
